The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Liver Fat Is Reduced by an Isoenergetic MUFA Diet in a Controlled Randomized Study in Type 2 Diabetic Patients
Open accessAbstract
OBJECTIVE: To evaluate the effects of qualitative dietary changes and the interaction with aerobic exercise training on liver fat content independent of weight loss in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS: With use of a factorial 2 × 2 randomized parallel-group design, 37 men and 8 women, aged 35-70 years, with type 2 diabetes in satisfactory blood glucose control on diet or diet plus metformin treatment were assigned to one of the following groups for an 8-week period: 1) high-carbohydrate/high-fiber/low-glycemic index diet (CHO/fiber group), 2) high-MUFA diet (MUFA group), 3) high-carbohydrate/high-fiber/low-glycemic index diet plus physical activity program (CHO/fiber+Ex group), and 4) high-MUFA diet plus physical activity program (MUFA+Ex group). Before and after intervention, hepatic fat content was measured by (1)H NMR. RESULTS: Dietary compliance was optimal and body weight remained stable in all groups. Liver fat content decreased more in MUFA (-29%) and MUFA+Ex (-25%) groups than in CHO/fiber (-4%) and CHO/fiber+Ex groups (-6%). Two-way repeated-measures ANOVA, including baseline values as covariate, showed a significant effect on liver fat content for diet (P = 0.006), with no effects for exercise training (P = 0.789) or diet-exercise interaction (P = 0.712). CONCLUSIONS: An isocaloric diet enriched in MUFA compared with a diet higher in carbohydrate and fiber was associated with a clinically relevant reduction of hepatic fat content in type 2 diabetic patients independent of an aerobic training program and should be considered for the nutritional management of hepatic steatosis in people with type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“POo contains a high proportion of unsaturated fatty acids (54% MUFAs, 10% PUFAs) (Table 1), which have been reported to increase β -oxidation rates (37, 39) and reduce liver fat (40).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907929 · Cited by 3,327
Bantle (2008) · doi:10.2337/dc08-s061 · Cited by 1,795
Automatic quantitation of localized in vivo1H spectra with LCModel
Provencher, S. W. (2001) · NMR in Biomedicine · doi:10.1002/nbm.698 · Cited by 1,640
Powell, E. E., Cooksley, G. W. E., Hanson, R., Searle, J., Halliday, J. W., & Powell, L. W. (1990) · Hepatology · doi:10.1002/hep.1840110114 · Cited by 1,473
Lavine, J. E. (2011) · JAMA · doi:10.1001/jama.2011.520 · Cited by 1,108
Johnson, N. A., Sachinwalla, T., Walton, D. W., Smith, K., Armstrong, A., Thompson, M. W., & George, J. (2009) · Hepatology · doi:10.1002/hep.23129 · Cited by 631
Targher, G., Bertolini, L., Poli, F., Rodella, S., Scala, L., Tessari, R., Zenari, L., & Falezza, G. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3541 · Cited by 582
Differential oxidation of individual dietary fatty acids in humans
DeLany, J. P., Windhauser, M. M., Champagne, C. M., & Bray, G. A. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.4.905 · Cited by 560
Hallsworth, K., Fattakhova, G., Hollingsworth, K. G., Thoma, C., Moore, S., Taylor, R., Day, C. P., & Trenell, M. I. (2011) · Gut · doi:10.1136/gut.2011.242073 · Cited by 529
Huang, M. A., Greenson, J. K., Chao, C., Anderson, L., Peterman, D., Jacobson, J. A., Emick, D. M., Lok, A. S.-F., & Conjeevaram, H. S. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41334.x · Cited by 441
Flagged first, then by citations
1 of the 41 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Treatment of NAFLD with diet, physical activity and exercise
Romero-Gómez, M., Zelber-Sagi, S., & Trenell, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.016 · Cited by 1,347
Mediterranean diet and nonalcoholic fatty liver disease
Anania, C., Perla, F. M., Olivero, F., Pacifico, L., & Chiesa, C. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i19.2083 · Cited by 353
Bacchi, E., Negri, C., Targher, G., Faccioli, N., Lanza, M., Zoppini, G., Zanolin, E., Schena, F., Bonora, E., & Moghetti, P. (2013) · Hepatology · doi:10.1002/hep.26393 · Cited by 350
Wong, V. W., Chan, R., Wong, G. L., Cheung, B., Chu, C. W., Yeung, D. K., Chim, A. M., Lai, J. W.-Y., Li, L. S., Sea, M. M.-M., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.04.013 · Cited by 346
Wong, V. W.-S., Wong, G. L.-H., Chan, R. S.-M., Shu, S. S.-T., Cheung, B. H.-K., Li, L. S., Chim, A. M.-L., Chan, C. K.-M., Leung, J. K.-Y., Chu, W. C.-W., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.08.011 · Cited by 319
Dietary carbohydrates and fats in nonalcoholic fatty liver disease
Yki-Järvinen, H., Luukkonen, P. K., Hodson, L., & Moore, J. B. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00472-y · Cited by 294
Zelber‐Sagi, S., Salomone, F., & Mlynarsky, L. (2017) · Liver International · doi:10.1111/liv.13435 · Cited by 273
Lifestyle modification in NAFLD/NASH: Facts and figures
Hallsworth, K., & Adams, L. A. (2019) · JHEP Reports · doi:10.1016/j.jhepr.2019.10.008 · Cited by 281
Nutrition, inflammation and liver-spleen axis
Barrea, L., Somma, C. D., Muscogiuri, G., Tarantino, G., Tenore, G. C., Orio, F., Colao, A., & Savastano, S. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1353479 · Cited by 317
Non-alcoholic fatty liver disease: A patient guideline
Francque, S. M., Marchesini, G., Kautz, A., Walmsley, M., Dorner, R., Lazarus, J. V., Zelber-Sagi, S., Hallsworth, K., Busetto, L., Frühbeck, G., et al. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100322 · Cited by 264
Dietary fat: From foe to friend?
Ludwig, D. S., Willett, W. C., Volek, J. S., & Neuhouser, M. L. (2018) · Science · doi:10.1126/science.aau2096 · Cited by 259
Low-glycemic index diets as an intervention for diabetes: a systematic review and meta-analysis
Zafar, M. I., Mills, K. E., Zheng, J., Regmi, A., Hu, S. Q., Gou, L., & Chen, L.-L. (2019) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqz149 · Cited by 245
Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?
Aron‐Wisnewsky, J., Warmbrunn, M. V., Nieuwdorp, M., & Clément, K. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.01.049 · Cited by 252
Fatty Acids Consumption: The Role Metabolic Aspects Involved in Obesity and Its Associated Disorders
Figueiredo, P. S., Inada, A. C., Marcelino, G., Cardozo, C. M. L., Freitas, K. D. C., Guimarães, R. D. C. A., de Castro, A. P., do Nascimento, V. A., & Hiane, P. A. (2017) · Nutrients · doi:10.3390/nu9101158 · Cited by 251
Gepner, Y., Shelef, I., Komy, O., Cohen, N., Schwarzfuchs, D., Bril, N., Rein, M., Serfaty, D., Kenigsbuch, S., Zelicha, H., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.04.013 · Cited by 236
The role of nutrition in non‐alcoholic fatty liver disease: Pathophysiology and management
Berná, G., & Romero‐Gómez, M. (2020) · Liver International · doi:10.1111/liv.14360 · Cited by 235
Nonalcoholic fatty liver disease in adults: current concepts in etiology, outcomes, and management
Marjot, T., Moolla, A., Cobbold, J. F., Hodson, L., & Tomlinson, J. W. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnz009 · Cited by 228
Properzi, C., O'Sullivan, T. A., Sherriff, J. L., Ching, H. L., Jeffrey, G. P., Buckley, R. F., Tibballs, J., MacQuillan, G. C., Garas, G., & Adams, L. A. (2018) · Hepatology · doi:10.1002/hep.30076 · Cited by 227
Lujan, P. V., Esmel, E. V., & Sacanella, E. (2021) · Nutrients · doi:10.3390/nu13051442 · Cited by 225
Impact of Nutritional Changes on Nonalcoholic Fatty Liver Disease
Perdomo, C. M., Frühbeck, G., & Escalada, J. (2019) · Nutrients · doi:10.3390/nu11030677 · Cited by 222
Treatments for NAFLD: State of Art
Mantovani, A., & Dalbeni, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052350 · Cited by 244
van Zuuren, E. J., Fedorowicz, Z., Kuijpers, T., & Pijl, H. (2018) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy096 · Cited by 177
Ullah, R., Rauf, N., Nabi, G., Ullah, H., Shen, Y., Zhou, Y., & Fu, J. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.30121 · Cited by 162
Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance
Yki‐Järvinen, H. (2015) · Nutrients · doi:10.3390/nu7115454 · Cited by 155
Fougerat, A., Montagner, A., Loiseau, N., Guillou, H., & Wahli, W. (2020) · Cells · doi:10.3390/cells9071638 · Cited by 150
Zelber‐Sagi, S., Godos, J., & Salomone, F. (2016) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x16638830 · Cited by 141
Smart, N. A., King, N., McFarlane, J. R., Graham, P. L., & Dieberg, G. (2018) · British Journal of Sports Medicine · doi:10.1136/bjsports-2016-096197 · Cited by 140
The Role of Diet and Nutritional Intervention for the Management of Patients with NAFLD
Francisco Barrera, M., & George, J. (2013) · Clinics in Liver Disease · doi:10.1016/j.cld.2013.09.009 · Cited by 137
Influence of Dietary Macronutrients on Liver Fat Accumulation and Metabolism
Parry, S. A., & Hodson, L. (2017) · Journal of Investigative Medicine · doi:10.1136/jim-2017-000524 · Cited by 141
Alferink, L. J. M., Jong, J. C. K., Erler, N. S., Veldt, B. J., Schoufour, J. D., de Knegt, R. J., Ikram, M. A., Metselaar, H. J., Janssen, H. L. A., Franco, O. H., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315940 · Cited by 130
The Influence of Dietary Fat on Liver Fat Accumulation
Green, C., & Hodson, L. (2014) · Nutrients · doi:10.3390/nu6115018 · Cited by 141
A Fad too Far? Dietary Strategies for the Prevention and Treatment of NAFLD
Moore, M. P., Cunningham, R. P., Dashek, R. J., Mucinski, J. M., & Rector, R. S. (2020) · Obesity · doi:10.1002/oby.22964 · Cited by 131
Lifestyle and Dietary Interventions in the Management of Nonalcoholic Fatty Liver Disease
Hannah, W. N., & Harrison, S. A. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4153-y · Cited by 129
Exercise and ectopic fat in type 2 diabetes: A systematic review and meta-analysis
Sabag, A., Way, K. L., Keating, S. E., Sultana, R. N., O'Connor, H. T., Baker, M. K., Chuter, V., George, J., & Johnson, N. A. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2016.12.006 · Cited by 126
Macronutrients and the Adipose-Liver Axis in Obesity and Fatty Liver
Duwaerts, C. C., & Maher, J. J. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.02.001 · Cited by 113
Eslamparast, T., Tandon, P., & Raman, M. (2017) · Nutrients · doi:10.3390/nu9080800 · Cited by 109
Meex, R. C. R., & Blaak, E. E. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900942 · Cited by 111
Regulating metabolic inflammation by nutritional modulation
Charles‐Messance, H., Mitchelson, K. A. J., Castro, E. D. M., Sheedy, F. J., & Roche, H. M. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.08.013 · Cited by 121
Pintó, X., Fanlo‐Maresma, M., Corbella, E., Corbella, X., Mitjavila, M. T., Moreno, J. J., Casas, R. M., Estruch, R., Corella, D., Bulló, M., et al. (2019) · Journal of Nutrition · doi:10.1093/jn/nxz147 · Cited by 109
Gut Microbiota and Lifestyle Interventions in NAFLD
Houghton, D., Stewart, C. J., Day, C. P., & Trenell, M. I. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040447 · Cited by 99
Mediterranean diet and NAFLD: what we know and questions that still need to be answered
Plaz Torres, M. C., Aghemo, A., Lleo, A., Bodini, G., Furnari, M., Marabotto, E., Miele, L., & Giannini, E. G. (2019) · Nutrients · doi:10.3390/nu11122971 · Cited by 97
Suárez, M., Boqué, N., Bas-Prior, J. M. D., Mayneris‐Perxachs, J., Arola, L., & Caimari, A. (2017) · Nutrients · doi:10.3390/nu9101052 · Cited by 93
Dietary Fibre as a Unifying Remedy for the Whole Spectrum of Obesity-Associated Cardiovascular Risk
Bozzetto, L., Costabile, G., Pepa, G. D., Ciciola, P., Vetrani, C., Vitale, M., Rivellese, A. A., & Annuzzi, G. (2018) · Nutrients · doi:10.3390/nu10070943 · Cited by 98
Self-citationThe influence of dietary fatty acids on liver fat content and metabolism
Hodson, L., Rosqvist, F., & Parry, S. A. (2019) · Proceedings of The Nutrition Society · doi:10.1017/s0029665119000569 · Cited by 98
Mediterranean diet and nonalcoholic fatty liver disease: molecular mechanisms of protection
Godos, J., Federico, A., Dallio, M., & Scazzina, F. (2016) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2016.1214239 · Cited by 94
Thomsen, M. N., Skytte, M. J., Samkani, A., Carl, M. H., Weber, P., Astrup, A., Chabanova, E., Fenger, M., Frystyk, J., Hartmann, B., et al. (2022) · Diabetologia · doi:10.1007/s00125-021-05628-8 · Cited by 90
Effects of physical activity upon the liver
Shephard, R. J., & Johnson, N. A. (2014) · European Journal of Applied Physiology · doi:10.1007/s00421-014-3031-6 · Cited by 93
Zhang, X., Lau, H. C.-H., & Yu, J. Q. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2024.100018 · Cited by 100
Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease
Lonardo, A., Ballestri, S., Targher, G., & Loria, P. (2014) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.965143 · Cited by 86
Jayedi, A., Zeraattalab-Motlagh, S., Ganjeh, B. J., Hosseini, Y., Jibril, A. T., Shahinfar, H., Mirrafiei, A., Hosseini, F. Z., & Shab‐Bidar, S. (2022) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqac066 · Cited by 89
Hydes, T., Ravi, S., Loomba, R. S., & Gray, M. E. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0067 · Cited by 90
Randomized Controlled Trial of a MUFA or Fiber-Rich Diet on Hepatic Fat in Prediabetes
Errazuriz, I., Dube, S., Slama, M. Q., VISENTIN, R., Nayar, S., O'Connor, H. T., Cobelli, C., Das, S. K., Basu, A., Kremers, W. K., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3722 · Cited by 79
George, E. S., Reddy, A., Nicoll, A. J., Ryan, M. C., Itsiopoulos, C., Abbott, G., Johnson, N. A., Sood, S., Roberts, S. K., & Tierney, A. C. (2022) · Liver International · doi:10.1111/liv.15264 · Cited by 76
Nutritional Management of Insulin Resistance in Nonalcoholic Fatty Liver Disease (NAFLD)
Conlon, B. A., Beasley, J. M., Aebersold, K., Jhangiani, S. S., & Wylie‐Rosett, J. (2013) · Nutrients · doi:10.3390/nu5104093 · Cited by 74
Khonche, A., Huseini, H. F., Gholamian, M., Mohtashami, R., Nabati, F., & Kianbakht, S. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.01.009 · Cited by 70
Chooi, Y. C., Zhang, Q. A., Magkos, F., Ng, M., Michael, N., Wu, X., Volchanskaya, V. S. B., Lai, X., Wanjaya, E. R., Elejalde, U., et al. (2024) · The American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2023.11.013 · Cited by 69
Microbiota, Fiber, and NAFLD: Is There Any Connection?
de, A. P.-M., Julián, M. T., Ramos, A., Puig‐Domingo, M., & Alonso, N. (2020) · Nutrients · doi:10.3390/nu12103100 · Cited by 69
Pepa, G. D., Vetrani, C., Lombardi, G., Bozzetto, L., Annuzzi, G., & Rivellese, A. A. (2017) · Nutrients · doi:10.3390/nu9101065 · Cited by 71
Self-citationDietary omega-3 and omega-6 polyunsaturated fatty acids modulate hepatic pathology
Khadge, S., Sharp, J. G., Thiele, G. M., McGuire, T. R., Klassen, L. W., Duryee, M. J., Britton, H. C., Dafferner, A. J., Beck, J., Black, P. N., et al. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.09.017 · Cited by 66
Low glycaemic index diets as an intervention for obesity: a systematic review and meta‐analysis
Zafar, M. I., Mills, K., Zheng, J., Peng, M., Ye, X., & Chen, L. L. (2018) · Obesity Reviews · doi:10.1111/obr.12791 · Cited by 70
Nutrition and Physical Activity in Nonalcoholic Fatty Liver Disease
de Oliveira, C. P. M. S., Sanches, P. D. L., de Abreu-Silva, E. O., & Marcadenti, A. (2015) · Journal of Diabetes Research · doi:10.1155/2016/4597246 · Cited by 64
Strong and persistent effect on liver fat with a Paleolithic diet during a two-year intervention
Otten, J., Mellberg, C., Ryberg, M., Sandberg, S., Kullberg, J., Lindahl, B., Larsson, C. L., Hauksson, J. B., & Olsson, T. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.4 · Cited by 60
Shidfar, F., Bahrololumi, S. S., Doaei, S., Mohammadzadeh, A., Gholamalizadeh, M., & Mohammadimanesh, A. (2018) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2018/1053710 · Cited by 58
Posicionamento sobre o Consumo de Gorduras e Saúde Cardiovascular – 2021
Izar, M. C. D. O., Lottenberg, A. M., Giraldez, V. Z. R., Santos, R. D., Machado, R. M., Bertolami, A., Assad, M. H. V., Saraiva, J. F. K., Faludi, A. Á., Moreira, A. S. B., et al. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20201340 · Cited by 78
Health Effects of Low-Carbohydrate Diets: Where Should New Research Go?
Wylie‐Rosett, J., Aebersold, K., Conlon, B. A., Isasi, C. R., & Ostrovsky, N. W. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0357-5 · Cited by 60
Alternative Methods of Bioactive Compounds and Oils Extraction from Berry Fruit By-Products—A Review
Piasecka, I., Wiktor, A., & Górska, A. (2022) · Applied Sciences · doi:10.3390/app12031734 · Cited by 57
The Coexistence of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
Kosmalski, M., Ziółkowska, S., Czarny, P. L., Szemraj, J., & Pietras, T. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11051375 · Cited by 55
Diabetes as a risk factor for MASH progression
Gancheva, S., Roden, M., & Castéra, L. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111846 · Cited by 60
Arrese, M. A., Francisco Barrera, M., Triantafilo, N., & Arab, J. P. (2019) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2019.1649981 · Cited by 56
Oily fish, coffee and walnuts: Dietary treatment for nonalcoholic fatty liver disease
Gupta, V. K. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i37.10621 · Cited by 50
Managing NAFLD in Type 2 Diabetes: The Effect of Lifestyle Interventions, a Narrative Review
Parry, S. A., & Hodson, L. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01281-6 · Cited by 50
Hajri, T., Zaiou, M., Fungwe, T. V., Ouguerram, K., & Besong, S. A. (2021) · Cells · doi:10.3390/cells10061355 · Cited by 49
Figueiredo, P. S., Inada, A. C., Fernandes, M. R., Arakaki, D. G., Freitas, K. D. C., Guimarães, R. D. C. A., do Nascimento, V. A., & Hiane, P. A. (2018) · Molecules · doi:10.3390/molecules23040877 · Cited by 48
Determinants of ectopic liver fat in metabolic disease
Bosy‐Westphal, A., Braun, W., Albrecht, V., & Müller, M. J. (2018) · European Journal of Clinical Nutrition · doi:10.1038/s41430-018-0323-7 · Cited by 51
Ganguli, S., Deleeuw, P., & Satapathy, S. K. (2019) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s188991 · Cited by 48
Lombardi, R., Iuculano, F., Pallini, G., Fargion, S. R., & Fracanzani, A. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228761 · Cited by 47
Marina, A., von Frankenberg, A. D., Suvag, S., Callahan, H. S., Kratz, M., Richards, T. L., & Utzschneider, K. M. (2014) · Nutrients · doi:10.3390/nu6114678 · Cited by 46
Otten, J., Stomby, A., Waling, M. U., Isaksson, A., Söderström, I., Ryberg, M., Svensson, M., Hauksson, J. B., & Olsson, T. (2018) · Diabetologia · doi:10.1007/s00125-018-4618-y · Cited by 42
Eating, diet, and nutrition for the treatment of non-alcoholic fatty liver disease
Semmler, G., Datz, C., & Trauner, M. (2022) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0364 · Cited by 43
Parker, A., & Kim, Y. (2019) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2019.0038 · Cited by 41
Yoshioka, N., Ishigami, M., Watanabe, Y., Sumi, H., Doisaki, M., Yamaguchi, T., Ito, T., Ishizu, Y., Kuzuya, T., Honda, T., et al. (2020) · Scientific Reports · doi:10.1038/s41598-019-57369-9 · Cited by 40
Current and Future Treatments in the Fight against Non-Alcoholic Fatty Liver Disease
Smeuninx, B., Boslem, E., & Febbraio, M. A. (2020) · Cancers · doi:10.3390/cancers12071714 · Cited by 39
Delarue, J., & Lallès, J. P. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500346 · Cited by 37
Modeling progressive non-alcoholic fatty liver disease in the laboratory mouse
Riordan, J. D., & Nadeau, J. H. (2014) · Mammalian Genome · doi:10.1007/s00335-014-9521-3 · Cited by 36
Hadefi, A., Arvanitakis, M., Trépo, E., & Zelber‐Sagi, S. (2023) · United European Gastroenterology Journal · doi:10.1002/ueg2.12443 · Cited by 40
Nonalcoholic Fatty Liver Disease: Identification and Management of High-Risk Patients
Cheung, A. C., Figueredo, C. J., & Rinella, M. E. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000058 · Cited by 35
Bozzetto, L., Costabile, G., Luongo, D., Naviglio, D., Cicala, V., Piantadosi, C., Patti, L., Cipriano, P., Annuzzi, G., & Rivellese, A. A. (2016) · Diabetologia · doi:10.1007/s00125-016-4110-5 · Cited by 35
Self-citationDietary Factors in Relation to Liver Fat Content: A Cross-sectional Study
Watzinger, C., Nonnenmacher, T., Grafetstätter, M., Sowah, S. A., Ulrich, C. M., Kauczor, H.-U., Kaaks, R., Schübel, R., Nattenmüller, J., & Kuhn, T. E. (2020) · Nutrients · doi:10.3390/nu12030825 · Cited by 33
Nutrition and Chronic Liver Disease
de la Fuente, R. A. (2022) · Clinical Drug Investigation · doi:10.1007/s40261-022-01141-x · Cited by 34
Hens, W., Taeymans, J., Cornelis, J., Gielen, J., Gaal, L. V., & Vissers, D. K. (2015) · Journal of Physical Activity and Health · doi:10.1123/jpah.2015-0560 · Cited by 35
Deciphering the role of aberrant DNA methylation in NAFLD and NASH
Vachher, M., Bansal, S., Kumar, B., Yadav, S., & Burman, A. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e11119 · Cited by 33
Management of fatty liver disease with the metabolic syndrome
Machado, M. V., & Cortez‐Pinto, H. (2014) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2014.903798 · Cited by 31
Bozzetto, L., Annuzzi, G., Costabile, G., Costagliola, L., Giorgini, M., Alderisio, A., Strazzullo, A., Patti, L., Cipriano, P., Mangione, A., et al. (2013) · Acta Diabetologica · doi:10.1007/s00592-013-0522-6 · Cited by 29
Self-citationRegulation of Fructose Metabolism in Nonalcoholic Fatty Liver Disease
Lodge, M., Dykes, R., & Kennedy, A. J. (2024) · Biomolecules · doi:10.3390/biom14070845 · Cited by 32
Maresca, L., D’Agostino, M., Castaldo, L., Vitelli, A., Mancini, M. E., Torella, G., Lucci, R., Albano, G., Forno, D. D., Ferro, M., et al. (2013) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2013.5234 · Cited by 28
Self-citationCostabile, G., Della Pepa, G., Salamone, D., Luongo, D., Naviglio, D., Brancato, V., Cavaliere, C., Salvatore, M., Cipriano, P., Vitale, M., et al. (2022) · Nutrients · doi:10.3390/nu14102178 · Cited by 27
Self-citationKaylan, K. B., & Paul, S. (2024) · Current Diabetes Reports · doi:10.1007/s11892-024-01558-y · Cited by 27
Kani, A. H., Alavian, S. M., Haghighatdoost, F., & Azadbakht, L. (2014) · Hepatitis Monthly · doi:10.5812/hepatmon.10939 · Cited by 27
London, A., Richter, M. M., Sjøberg, K. A., Albrechtsen, N. J. W., Považan, M., Drici, L., Schaufuss, A., Madsen, L., Øyen, J., Madsbad, S., et al. (2024) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2024.06.006 · Cited by 26
Eekelen, E. W.-V., Verkouter, I., Peters, H. P. F., Alssema, M., de Roos, B. G., Schrauwen‐Hinderling, V. B., Roumans, K. H. M., Schoones, J. W., Zock, P. L., Schrauwen, P., et al. (2020) · European Journal of Clinical Nutrition · doi:10.1038/s41430-020-00778-1 · Cited by 27
Metadata
- Authors
- Bozzetto, L., Prinster, A., Annuzzi, G., Costagliola, L., Mangione, A., Vitelli, A., Mazzarella, R., Longobardo, M., Mancini, M., Vigorito, C., Riccardi, G., & Rivellese, A. A.
- Affiliations
- Federico II University Hospital (IT)
- Institute of Biostructure and Bioimaging (IT)
- University of Naples Federico II (IT)
- Corresponding author
- Rivellese, Angela A.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2012-06-12
- Volume
- 35
- Issue
- 7
- Pages
- 1429-1435
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3379578
- OpenAlex
- W1965542427
- Cited by
- 227
- References
- 41
- Citations by year
- 2026: 4 · 2025: 12 · 2024: 17 · 2023: 15 · 2022: 20 · 2021: 19 · 2020: 25 · 2019: 22 · 2018: 22 · 2017: 20 · 2016: 17 · 2015: 6 · 2014: 13 · 2013: 11 · 2012: 4
- FWCI
- 8.11
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- FP7 Food, Agriculture and Fisheries, Biotechnology
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- type 2 diabetes, hepatic steatosis, liver fat, monounsaturated fatty acids, dietary fat composition, isocaloric diet, aerobic exercise training, dietary fiber, low glycemic index diet, metformin
- MeSH terms
- Adult, Aged, Diabetes Mellitus, Type 2, Fats, Fatty Acids, Monounsaturated, Fatty Liver, Female, Humans, Liver, Male, Metformin, Middle Aged, Exercise
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review